Lexicon Pharma (LXRX) Tops Q2 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Lexicon Pharma (LXRX) Tops Q2 EPS by 11c

Lexicon Pharmaceuticals Reports Second Quarter 2017 Financial Results And Provides A Business Update

August 1, 2017 7:00 AM EDT

THE WOODLANDS, Texas, Aug. 1, 2017 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended June 30, 2017 and provided an overview of key milestones for the company's commercial product, XERMELO®, and its pipeline drug candidates.

"I am extremely pleased with our performance in the first full quarter of the XERMELO launch as we continue to make significant progress in growing our prescriber base and providing access to XERMELO. This momentum, along with... More